VEGFA and wet macular degeneration: Consequently, alternative treatments for wet-AMD are needed, and intravitreal injections of VTI-1002, either alone or in conjunction with anti-VEGF biologics (where they may exhibit synergistic effects on VEGF signaling), represent an exciting potential avenue for treatment of wet-AMD.